@Fibonazzo@subdependent@ove_vapaalla Näkyikö jälkimarkkinankin aikana perjantaina osto-ja myyntilaidat ihan normaalisti ja mikä aikaikkuna oli myydä 0,485:llä?
@DineenRon@dmeinvestor If you want exposure to tungsten, take a look at $EQR, it’s very speculative but could have some nice upside from here. We’ve talked to management and the sell side.
Price action means the market doesn’t believe $HROW can hit their targets over the next 6 quarters… if they do… this stock could be $150+ stock within 18 months… even if they only do $200M in 2027 Q4… it still puts them on track for $900M+ in 2028 which doesn’t include G-MELT… with ebitda margins in the 35-40% range by then (if not higher)… we’d be looking at $340M+ of ebitda in 2028… throw a 20x NTM multiple on that (conservative) and use 40M shares = $170 stock price in early 2028 aka 5-bagger in 18 months. LFG!!!
Great news for $NRXS!
New medical policy coverage for PENFS from a major national health insurer.
The policy spans multiple states and covers ~18M health plan members.
$NRXS remains one of my largest positions, but I rarely discuss it here given the limited liquidity.
@tuohenpolttaja@onlyfaxtony Interactive Brokersilla ainakin, jos margin tili. Almonty pudonnut tänään melkein 10% ja enää 16,57. Shorttaisitko vielä silläkin hinnalla?
@JarmoFriman@peter59144504 Goldminers-osastolta mitkähän voisi olla sen alan Apple, Google ja Amazon ja EQR, mihin onnenpyöriin voisi kokeilumielessä hajauttaa?
This is why we own $EQR.AX — trading at less than 3x NTM EV/EBITDA… could/should generate $1.2B of net income over the next 8 quarters with current market cap at $2B
I would not be surprised if this stock is a 3-bagger from here in the next 12 months.
$EQR.AX has been ripping higher (+100% in the past 6 weeks) and rightly so when you look at what Tungsten prices have done (see below).
$EQR.AX has a market cap around $2B and I'm relatively confident they'll generate at least $2B of ebitda over the next 8-10 quarters.
Not too hard to understand why this stock might see a massive re-rating soon with buybacks and a US Nasdaq listing on the horizon.
NFA.
DYOR.
*We are long $EQR.AX at @FirstWaveFund